Abstract:Objective To explore the VEGF,Flt-1 and KDR mRNA and protein expression in primary gallbladder carcinoma (PGC) and their correlation with primary gallbladder carcinoma clinicopathological characteristics.Methods The VEGF,Flt-1 and KDR mRNA and protein expression in the fresh resected samples of 21 cases of primary gallbladder carcinoma and 10 cases of gallbladder adenomaous ployps (GAP) was deteched by RT-PCR and immunohistochemistry.The correlation between VEGF,Flt-1 and KDR protein positive expression in PGC and the clinicopathological characteristics of PGC was analysed as well.Results The VEGF mRNA positive expression rates in all PGC and GAP cases were 90.47% (19/21) and 20% (2/10),the Flt-1 mRNA positive expression rates were 71.42% (15/21) and 0 (0/10) and the KDR mRNA positive expression rates were 85.71% (18/21) and 10% (1/10),respectively,with the difference being significant between PGC cases and GAP cases (P 0.05).The VEGF protein positive expression rates of all PGC and GAP cases were 80.95% (17/21) and 20% (2/10),the Flt-1 protein positive expression rates were 60.90% (13/21) and 10% (1/10) and the KDR protein positive expression rates were 76.19% (16/21) and 10% (1/10),respectively,with the difference being significant between two groups (P 0.05).The VEGF,Flt-1 and KDR protein positive expression rates in PGC cases with liver infiltration,lymphatic metastasis and Nevin IV and V stages were significantly higher than those in the cases withou liver infiltration,lymphatic metastasis and Nevin I,Ⅱ and Ⅲ stages of PGC (P 0.05).However,the positive expression rates of VEGF,Flt-1[BG)W][LM][BG(][BHDWG8*2,WK42ZQ0W] and KDR protein had no difference among the high,middle and low differentiation of PGC cases (P 0.05).Conclusion The VEGF,Flt-1 and KDR mRNA and protein were all overexpressed in the cases of PGC and the overexpressions of VEGF,Flt-1 and KDR protein were significantly correlated with PGC liver infiltration,lymphatic metastasis and Nevin IV and V stages,but not with the PGC pathological differentiation.

A Study on the Expressions of P21waf1 and P53 Protein in Cholangiocarcinoma

The relationship of expression of p53,p21,Ki-67 and VEGF and bladder cancer stage,grade and prognosis

Expression of C-fos and K-ras proteins during carcinogenesis of intrahepatic cholangiocarcinoma and its significance

VEGF, Flt-1 and KDR Mrna and Protein Expression in Primary Gallbladder Carcinoma and Their Correlation with Primary Gallbladder Carcinoma Clinicopathological Characteristics

EXPRESSION AND SIGNIFICANCE OF p21WAF1 AND p53 IN HEPATIC CELL CARCINOMA

Relationship Between P21,p53 Expression and Single Nucleotide Polymorphism with Hepatocellular Carcinoma

Expression of pGSK-3α/β (Tyr279/216) and XIAP proteins in cholangiocarcinoma and their clinical significance

Expression and significance of P53 and P21waf1/cip1 in cervical squamous cell carcinoma

The Expression and Clinical Significance of P53,P21 and P185 in Gastric Cancer

Clinical Significance of Expressions of P21 and P53 Proteins and PCNA in Pancreatic Cancer

The expression of P53 gene and its clinical significance in hepatocellular carcinoma

Association of P53, P16, and Vascular Endothelial Growth Factor Protein Expressions with the Prognosis and Metastasis of Gallbladder Cancer

Overexpressions of Ck2 Beta and Xiap Are Associated with Poor Prognosis of Patients with Cholangiocarcinoma

The expression of p53 protein and p21WAFI/cipl/sdil in gastric carcinoma

Expression of P21(waf1/cip1) and P53 Proteins in Gastric Carcinoma: Its Relationships with Cell Proliferation Activity and Prognosis.

Analysis of Transcriptome in the Relationship Between Expression of PRC1 Protein and Prognosis of Patients with Cholangiocarcinoma

THE EXPRESSION AND SIGNIFICANCE OF P53 AND P21(WAF1/CIP1) IN THYROID CARCINOMA

Expression of Multidrug Resistance-Related Proteins MRP1/LRP/GST-π in Carcinoma of the Gallbladder and Cholangiocarcinoma

Expression of E-cadherin, β-catenin, MMP-7 and their significances in cholangiocarcinoma

Prognostic significance of bcl-2 and p53 expression in colorectal carcinoma

Investigation of transcriptional and immunological disparities among patient groups with varied prognostic risk factors in cholangiocarcinoma